RB
Radhika Bagla
About Radhika Bagla
Data last updated:
Radhika Bagla is a Director at Redcliffe Lifetech Private Limited (since 2023), Director at Crysta Ivf Life Private Limited (since 2023) and Director at Standard Diagnostics Private Limited (since 2022), and holds 3 more current directorships. The companies operate in Healthcare. The 5 current companies with reported revenue have a combined latest revenue of ₹524 Cr; the largest is Redcliffe Lifetech Private Limited at ₹436 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Aug 2023 | 2021 | ₹436 Cr (FY 2025) | Active | |
| Director | 01 Nov 2023 | 2021 | ₹46.62 Cr (FY 2025) | Active | |
| Director | 04 Aug 2022 | 2020 | ₹41.05 Cr (FY 2023) | Active | |
| Director | 28 Jun 2022 | 2021 | ₹44.2 Lakh (FY 2025) | Active | |
| Director | 01 Aug 2023 | 2017 | ₹7.2 Lakh (FY 2025) | Active | |
| Director | 26 Jun 2024 | 2024 | Active |
Board colleagues of Radhika Bagla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aditya Kandoi | 01060948 | Redcliffe Lifetech Private Limited , Redcliffe Life Images Private Limited and 1 more | Director |
| Aditya Kandoi | Redcliffe Lifetech Private Limited | Ceo | |
| Dhiraj Jain | 07124088 | Redcliffe Lifetech Private Limited , Redcliffe Life Images Private Limited and 1 more | Director |
| Rohit Jalan | 10373301 | Redcliffe Lifetech Private Limited , Crysta Ivf Life Private Limited and 3 more | Director |
| Neeta Jain | 00055141 | Crysta Ivf Life Private Limited | Director |
| Neeta Jain | Crysta Ivf Life Private Limited | Ceo | |
| Sanjay Aggarwal | 00026713 | Standard Diagnostics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Radhika Bagla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Radhika Bagla
Radhika Bagla currently holds 6 directorships: Redcliffe Lifetech Private Limited (Director, since 01 Aug 2023, revenue ₹436 Cr (FY 2025)); Crysta Ivf Life Private Limited (Director, since 01 Nov 2023, revenue ₹46.62 Cr (FY 2025)); Standard Diagnostics Private Limited (Director, since 04 Aug 2022, revenue ₹41.05 Cr (FY 2023)); Redcliffe Life Images Private Limited (Director, since 28 Jun 2022, revenue ₹44.2 Lakh (FY 2025)); Redcliffe Lifescience Private Limited (Director, since 01 Aug 2023, revenue ₹7.2 Lakh (FY 2025)); and 1 more.
Radhika Bagla was first appointed on 28 Jun 2022 as Director at Redcliffe Life Images Private Limited. The most recent appointment on record is 26 Jun 2024 at Crysta Ivf And Fertility Private Limited.
The 5 current companies of Radhika Bagla that report revenue have a combined latest revenue of ₹524 Cr: Redcliffe Lifetech Private Limited ₹436 Cr (FY 2025); Crysta Ivf Life Private Limited ₹46.62 Cr (FY 2025); Standard Diagnostics Private Limited ₹41.05 Cr (FY 2023); Redcliffe Life Images Private Limited ₹44.2 Lakh (FY 2025); Redcliffe Lifescience Private Limited ₹7.2 Lakh (FY 2025).
The current boards of Radhika Bagla's companies include Aditya Kandoi (Redcliffe Lifetech Private Limited), Aditya Kandoi (Redcliffe Lifetech Private Limited), Dhiraj Jain (Redcliffe Lifetech Private Limited), Rohit Jalan (Redcliffe Lifetech Private Limited), Neeta Jain (Crysta Ivf Life Private Limited), Neeta Jain (Crysta Ivf Life Private Limited), among others.